2024
DOI: 10.1097/cco.0000000000001098
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative immunotherapy in nonsmall cell lung cancer

Renzhi Zhang,
Chun Zou,
Liang Zeng
et al.

Abstract: Purpose of review To evaluate and summarize the current clinical efficacy, safety, treatment patterns, and potential biomarkers, to guide future treatment strategies for nonsmall cell lung cancer (NSCLC), improve patient prognosis, and provide a scientific basis for personalized therapy. Recent findings In recent years, the class of immune checkpoint inhibitors (ICIs), with programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors at the helm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 54 publications
0
0
0
Order By: Relevance